• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 99-113 of 318 results

1022 Exhibit: Stewart B Leavitt, PhD, ed, Evidence for the Efficacy of Naltrexone in...

Document IPR2018-00943, No. 1022-20 Exhibit - Stewart B Leavitt, PhD, ed, Evidence for the Efficacy of Naltrexone in the Treatment of Alcohol Dependence Alcoholism (P.T.A.B. Apr. 20, 2018)

cite Cite Document
Analyze

1053 Exhibit: Schenker et al, Antecedent liver disease and drug toxicity

Document IPR2018-00943, No. 1053-48 Exhibit - Schenker et al, Antecedent liver disease and drug toxicity (P.T.A.B. Apr. 20, 2018)

cite Cite Document
Analyze

1007 Exhibit: US Serial Number 11083,167, Final Rejection, July 20, 2010

Document IPR2018-00943, No. 1007-7 Exhibit - US Serial Number 11083,167, Final Rejection, July 20, 2010 (P.T.A.B. Apr. 20, 2018)

cite Cite Document
Analyze

1016 Exhibit: US Securities and Exchange Commission, FORM 10 K

Document IPR2018-00943, No. 1016-53 Exhibit - US Securities and Exchange Commission, FORM 10 K (P.T.A.B. Apr. 20, 2018)

cite Cite Document
Analyze

1058 Exhibit: Filing Details for Alkermes Inc 10 K dated July 1, 2007 from the Secur...

Document IPR2018-00943, No. 1058-60 Exhibit - Filing Details for Alkermes Inc 10 K dated July 1, 2007 from the Security and Exchange Commissions EDGAR Online Filing System (P.T.A.B. Apr. 20, 2018)

cite Cite Document
Analyze

Letter

Document VIVITROL, 021897, Letter (Orange Book May. 8, 2020)

cite Cite Document
Analyze

Label

Document VIVITROL, 021897, Label (Orange Book May. 8, 2020)

cite Cite Document
Analyze

Label

Document VIVITROL, 021897, Label (Orange Book Sep. 6, 2019)

cite Cite Document
Analyze

Letter

Document VIVITROL, 021897, Letter (Orange Book Sep. 6, 2019)

cite Cite Document
Analyze

Label

Document VIVITROL, 021897, Label (Orange Book Dec. 28, 2018)

cite Cite Document
Analyze

Letter

Document VIVITROL, 021897, Letter (Orange Book Dec. 28, 2018)

cite Cite Document
Analyze

1083 Exhibit: Milo Gibaldi and Donald Perrier, Pharmacokinetics, 1 Drugs and Phar...

Document IPR2018-00943, No. 1083-136 Exhibit - Milo Gibaldi and Donald Perrier, Pharmacokinetics, 1 Drugs and Pharmaceutical Sciences 2d ed rev expanded 2007 (P.T.A.B. May. 7, 2019)

cite Cite Document
Analyze

1084 Exhibit: Kogan et al, Estimation of the Systemic Availability and Other Pharma...

Document IPR2018-00943, No. 1084-137 Exhibit - Kogan et al, Estimation of the Systemic Availability and Other Pharmacokinetic Parameters of Naltrexone in Man After Acute and Chronic Oral Administra...

cite Cite Document
Analyze

1069 Exhibit: Bioavailability and Bioequivalence Studies for Orally Administered Dr...

Document IPR2018-00943, No. 1069-122 Exhibit - Bioavailability and Bioequivalence Studies for Orally Administered Drug Products General Considerations, Guidance for Industry (P.T.A.B. May. 7, 2019...

cite Cite Document
Analyze

1079 Exhibit: Nikolaj Kunoe et al, Injectable and Implantable sustained release nalt...

Document IPR2018-00943, No. 1079-132 Exhibit - Nikolaj Kunoe et al, Injectable and Implantable sustained release naltrexone in the treatment of opioid addiction (P.T.A.B. May. 7, 2019)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 7 8 9 10 11 ... >>